What topics does this cannabis study cover?

This study covers research on: CBD.

Where was this research published?

Published in Toxicology letters on February 1, 2026.

CBD

CBD's hidden risks: Navigating stem cell safety

Q: What did this research study find?

**High CBD concentrations (≥10 µM) cause significant cell death** through *caspase-dependent apoptosis*

Effects of cannabidiol on the viability and neuronal differentiation of human iPS cells.

Toxicology letters • February 1, 2026 • Moderately Relevant

🤖

AI Summary

This groundbreaking study explores the potential risks of cannabidiol (CBD) during early human neural development, revealing critical insights into its effects on stem cells. Researchers investigated how different concentrations of CBD impact human induced pluripotent stem cells (hiPSCs), uncovering a delicate balance between safe and toxic levels of the compound.

The research demonstrated that high concentrations of CBD (≥10 µM) can significantly reduce cell viability through a process of caspase-dependent apoptosis. Notably, while low concentrations (0.001-1 µM) did not disrupt neural differentiation, higher doses caused marked cytotoxicity and impaired cell colony formation. This finding suggests a narrow therapeutic window that requires extreme caution, particularly for pregnant individuals or those considering CBD use during critical developmental stages.

These results carry substantial implications for CBD usage, emphasizing the need for careful, concentration-dependent evaluation of its potential developmental neurotoxicity. The study underscores the complexity of cannabidiol's biological interactions and highlights the importance of further research to fully understand its safety profile across different developmental stages.

💡 Key Findings

High CBD concentrations (≥10 µM) cause significant cell death through caspase-dependent apoptosis

High

85%

Narrow concentration window exists between safe and toxic CBD levels during early neural development

Good

75%

Low CBD concentrations (0.001-1 µM) do not disrupt neural differentiation or transcriptional profiles

High

80%

📄 Original Abstract

Cannabidiol (CBD) is a non-psychoactive cannabinoid with increasing global use, yet safety data during pregnancy remain limited. Preclinical studies suggest possible developmental neurotoxicity. Here, we examined the effects of CBD (0.001-100 μM) on human induced pluripotent stem cells (hiPSCs) using cell counting, morphology, flow cytometry, and qRT-PCR. Acute exposure to CBD (≥10 μM) markedly reduced hiPSC viability, accompanied by morphological disruptions and upregulation of caspase-3 and -7 within 3-5 h. These effects were significantly attenuated by the pan-caspase inhibitor Z-VAD-FMK, indicating caspase-dependent apoptosis as a key mechanism. Chronic exposure to CBD (0.001-1 μM) for 7 days did not alter transcriptional profiles of Nanog, Pax6, or Map2 during neural ectodermal induction, and immunocytochemical analyses further confirmed that early neuroectodermal morphology was preserved, with comparable PAX6- and NESTIN-positive populations in CBD-treated and control cultures. However, higher CBD concentrations caused marked cytotoxicity and impaired colony formation. These findings define a narrow concentration window between safe and toxic levels, highlighting stage-specific vulnerability to CBD during early development. Use of CBD in pregnancy should therefore be approached cautiously, considering potential risks to fetal neural development.

Paper Type

📄 Research

Publication

Journal: Toxicology letters
Published: February 1, 2026
PMID: 41482016
DOI: 10.1016/j.toxlet.2025.111812

Authors (2)

Koushirou Sogawa Department of Environmental and Health Sciences, Shonan University of Medical Sciences, 16-10 Kamishinano, Yokohama, Kanagawa 224-0806, Japan.
Masahiko Funada Department of Pharmacology, Faculty of Pharmaceutical Sciences, Shonan University of Medical Sciences, 16-10 Kamishinano, Yokohama, Kanagawa 224-0806, Japan. Electronic address: masahiko.funada@sums.ac.jp.

MeSH Keywords

Humans Cannabidiol Induced Pluripotent Stem Cells Cell Survival Cell Differentiation Apoptosis Neurons Neurogenesis Dose-Response Relationship, Drug PAX6 Transcription Factor